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Abstract
Radiation-induced normal brain injury is associated with acute and/or chronic inflammatory responses, and has been a major
concern in radiotherapy. Recent studies suggest that microglial activation is a potential contributor to chronic inflammatory
responses following irradiation; however, the molecular mechanism underlying the response of microglia to radiation is
poorly understood. c-Jun, a component of AP-1 transcription factors, potentially regulates neural cell death and
neuroinflammation. We observed a rapid increase in phosphorylation of N-terminal c-Jun (on serine 63 and 73) and MAPK
kinases ERK1/2, but not JNKs, in irradiated murine microglial BV2 cells. Radiation-induced c-Jun phosphorylation is
dependent on the canonical MEK-ERK signaling pathway and required for both ERK1 and ERK2 function. ERK1/2 directly
interact with c-Jun in vitro and in cells; meanwhile, the JNK binding domain on c-Jun is not required for its interaction with
ERK kinases. Radiation-induced reactive oxygen species (ROS) potentially contribute to c-Jun phosphorylation through
activating the ERK pathway. Radiation stimulates c-Jun transcriptional activity and upregulates c-Jun-regulated
proinflammatory genes, such as tumor necrosis factor-a, interleukin-1b, and cyclooxygenase-2. Pharmacologic blockade
of the ERK signaling pathway interferes with c-Jun activity and inhibits radiation-stimulated expression of c-Jun target
genes. Overall, our study reveals that the MEK-ERK1/2 signaling pathway, but not the JNK pathway, contributes to the c-Jun-
dependent microglial inflammatory response following irradiation.
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Introduction
Radiation therapy is an important modality of treatment for
brain tumors and cancers that have metastasized to the brain.
However, the side effects of radiation therapy, such as acute and
chronic brain injury, are a major concern and limit its clinical
application [1]. A growing body of evidence supports the
hypothesis that radiation-induced brain injury is driven in part
by an acute and/or chronic inflammatory response [2,3]. As the
resident innate immune cells in the brain, microglia are a pre-
dominant source of proinflammatory factors [4,5]. Radiation
stimulates the transformation of resting microglial cells to a reactive
state, consequently leading to the up-regulation of proinflamma-
tory cytokines such as tumor necrosis factor-a (TNF-a), inter-
leukins, and cyclooxygenase-2 (COX-2) [3,6,7,8,9]. Excessive
amounts of proinflammatory cytokines secreted by activated
microglia can cause neurotoxicity in neurodegenerative diseases
[5] and also have been implicated in radiation-induced brain
injury. The release of cytokines is deleterious to neurons, since it
can alter the microenvironment of neural stem and progenitor
cells and may further block neurogenesis [3]. Sustained microglial
activation observed in irradiated rodent brains was associated with
a concomitant decline in neurogenesis in the hippocampus and
spatial memory retention deficits [10,11]. Blocking inflammation
with indomethacin, a common nonsteroidal anti-inflammatory
drug, inhibited radiation-induced microglial activation and
mitigated impaired neurogenesis by radiation [3]. To date, the
molecular mechanisms underlying radiation-stimulated microglial
activation remain largely unclear.
Activation of transcription factors, such as AP-1 proteins, is one
of the cellular responses to ionizing radiation [12]. c-Jun,
a component of the AP-1 transcription factors, regulates expres-
sion of many genes, including inflammatory and cytokine genes,
which contain consensus AP-1 binding sites in their promoter
regions [13,14,15,16]. Therefore, c-Jun has been considered to be
an important regulator for neural cell death and neuroinflamma-
tion [17]. c-Jun generally forms homodimers or heterodimers with
other AP-1 proteins and binds to specific DNA elements in
promoters to regulate target genes. c-Jun protein is composed of
several structural and functional domains. Its N-terminus (aa1-
190) contains a c-Jun N-terminal kinase (JNK) binding domain
(JBD) and a transactivation domain. The C-terminal region
(aa257-308) contains a leucine zipper (bZip) type DNA binding
domain. The middle part is a hinge region (aa191-256) [17]. The
transcriptional activity of c-Jun is regulated by different post-
translational modifications [17,18]. Among these, phosphorylation
plays a critical role in regulating c-Jun function. Phosphorylation
can occur at multiple sites on the c-Jun protein [17,19].
Phosphorylation on Ser63 and Ser73 of N-terminal c-Jun is
normally associated with its enhanced transcriptional activity
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36739Figure 1. Radiation-induced phosphorylation of c-Jun and ERK1/2 in BV2 cells. (A) BV2 cells were irradiated with a single dose of 10 Gy,
and sampled at the time points indicated. Cell lysates were sequentially immunoblotted with indicated antibodies in Western blot assays to detect
phosphorylated and total proteins of c-Jun, ERK1/2, and JNK. b-actin was used as a loading control. Increased phosphorylation was found for c-Jun
and ERK1/2 post irradiation, but not for JNKs. There was no obvious change for total c-Jun. The right panel shows the fold change for
phosphorylation of c-Jun (Ser63 and Ser73) and ERK1/2 following irradiation. Data represent mean 6 SD and the significant differences compared to
control were indicated as *p,0.05 or **p,0.01. (B) BV2 cells were irradiated with different doses as shown and phosphorylation of c-Jun and ERK1/2
was detected at 0.5 and 1 h post-irradiation. Regardless of dose levels, radiation markedly stimulated phosphorylation of c-Jun and ERK1/2.
doi:10.1371/journal.pone.0036739.g001
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PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36739[17,20]. Conversely, C-terminal phosphorylation of c-Jun de-
creases its ability to bind to target gene promoters [17].
c-Jun can be phosphorylated by many different types of kinases,
especially mitogen-activated protein kinases (MAPKs) [21].
MAPKs belong to a Ser/Thr protein kinase family that plays
a pivotal role in regulating activation of transcription factors. The
MAPK cascades comprise the three-kinase module (MAPKKK,
MAPKK and MAPK), and are evolutionarily conserved and
ubiquitously expressed in eukaryotes [22]. Sequential activation
from MAPKKK to MAPK transmits multiple cellular stimuli into
nuclei to modulate gene expression and eventually initiate cellular
responses. In addition to essential functions in many physiological
processes including cell proliferation, senescence, differentiation,
and apoptosis, MAPKs mediate the response to extracellular
stimuli such as ionizing radiation and toxic stresses [21].
JNKs, ERK1/2 (p44 and p42), and p38 MAPKs represent the
well characterized MAPK subfamilies. Various AP-1 proteins are
regulatory targets of these MAPKs. JNKs have been recognized as
the predominant c-Jun kinases targeting Ser63 and Ser73 in the c-
Jun N-terminus; whereas ERK1/2 and p38 are critical for c-fos
phosphorylation [22]. Each member of the MAPK superfamily
kinases is involved in distinct signal cascades, respectively;
however, they are also functionally related in certain circum-
stances. A recent study has demonstrated that ERK1/2 function-
ally substituted for JNK1/JNK2 to mediate phosphorylation of
Ser63/73 on c-Jun protein in vitro and in mouse fibroblasts [19],
indicating a crosstalk between JNK and the ERK1/2 signaling
pathways. However, the functional relationship between the
ERK1/2 cascade and c-Jun function still remains largely un-
determined.
In this study, we used BV2 murine microglial cells as a model to
explore the molecular signaling pathway required for c-Jun
activation in response to ionizing radiation. We discovered that
the canonical MAPK MEK-ERK1/2 signaling cascade, but not
JNK pathway, directly mediated c-Jun N-terminal phosphoryla-
tion. Blockade of MEK-ERK1/2 signaling pathway compromised
c-Jun activity, leading to a decreased expression of several
proinflammatory genes regulated by c-Jun.
Results
Ionizing radiation leads to a rapid phosphorylation of c-
Jun and ERK1/2, but not JNKs
BV2 cells were irradiated with a single dose of 10 Gy c-ray and
cell lysates were collected for Western blot analyses. Radiation
resulted in a prominent increase in c-Jun phosphorylation on
Ser63 and Ser73 (Figure 1A), the critical phosphorylation sites
correlating with enhanced transcriptional activity of c-Jun [23].
The induction of phosphorylation by radiation was rapid and
sustained for several hours. Meanwhile, total c-Jun protein
remained unchanged in the irradiated cells, indicating that the
accumulation of phosphorylated c-Jun was not due to transcrip-
tional upregulation. JNKs have been known to phosphorylate c-
Jun on Ser63 and Ser73 residues. Unexpectedly, we did not
observe concurrently activated JNKs following irradiation, in-
dicated by their unchanged phosphorylation status on Thr183 and
Tyr185 sites (Figure 1A). In contrast, radiation stimulated rapid
phosphorylation of ERK1 and ERK2. Similar results were found
in BV2 cells treated with different irradiation doses from 2.5 to
15 Gy. As shown in Figure 1B, phosphorylation was increased
under each of the conditions for both c-Jun and ERK1/2.
Nevertheless, induction patterns of the phosphorylation were
somewhat different between low-dose and high-dose treated cells.
For example, peak phosphorylation for c-Jun and ERK1/2
appeared at 0.5 h for lower doses of irradiation (2.5 and 5 Gy),
but at 1 h for the highest dose (15 Gy). Moreover, there was an
apparent correlation between post-irradiation phosphorylation
levels of c-Jun and ERK1/2, suggesting that ERK1/2 mediate
radiation-stimulated c-Jun phosphorylation.
ERK1 and ERK2 are required for radiation-induced c-Jun
phosphorylation in BV2 cells
To determine whether ERK1 and ERK2 regulate c-Jun
phosphorylation in BV2 cells, ERK1 and ERK2 expression vectors
were cotransfected into BV2 cells in increasing amounts to
overexpress these two proteins. Forty-eight hours after trans-
fection, c-Jun phosphorylation on Ser63 showed a dose-dependent
increase, indicating the capability of ERK1/2 to stimulate c-Jun
phosphorylation (Figure 2A). To further substantiate the role of
ERK1/2 in radiation-induced c-Jun phosphorylation, an in-
hibitory assay was performed. The ERK inhibitor was found to
attenuate phosphorylation of ERK1/2 but not JNK kinases and
accordingly markedly reduced radiation-mediated phosphoryla-
tion of Ser63 on c-Jun (Figure 2B).
We did not observe any effects of ERK inhibitor on the activity
of JNKs (Figure 2B). Nevertheless, to exclude other potential non-
specific effects of this inhibitor and determine which ERK isoform
is more important for c-Jun phosphorylation, we conducted
shRNA-mediated gene knockdown experiments for ERK1 and
ERK2. Two lentiviral shRNA constructs with different target
sequences were created for each of the kinases. Except for sh-
ERK1-536, the other three constructs (sh-ERK1-974, sh-ERK2-
321, and sh-ERK2-772) led to a specific knockdown for their
corresponding targets, respectively (Figure 2C). Consistently, these
effective shRNA constructs almost eliminated radiation-induced
phosphorylation of ERK1 and ERK2 in BV2 cells (Figure 2D).
However, individual infection with these constructs did not
decrease radiation-induced c-Jun phosphorylation (Figure 2D).
To determine whether ERK1 and ERK2 have functional
redundancy in mediating c-Jun phosphorylation, we simultaneous-
ly silenced these two kinases using the shRNA combinations of sh-
ERK1-974/sh-ERK2-321 and sh-ERK1-974/sh-ERK2-772.
Both shRNA combinations markedly decreased protein levels of
ERK1 and ERK2 as well as their phosphorylation in the
irradiated cells (Figure 2E). Accordingly, depletion of both
ERK1 and ERK2 suppressed radiation-stimulated phosphoryla-
tion of c-Jun (Figure 2E). The reduced c-Jun phosphorylation was
not due to JNK protein function, since the ERK kinase shRNAs
did not affect JNK expression (Figure 2F). It is noteworthy that
ERK1/2 silencing only reduced c-Jun phosphorylation to the
levels comparable to that of non-irradiated control cells, suggesting
that the basal level of c-Jun phosphorylation is maintained by
other kinases, such as JNKs.
ERK1 and ERK2 interact with c-Jun
Upon phosphorylation, the cytosolic ERK1/2 proteins trans-
locate into the nucleus to modulate many nuclear targets,
including transcription factors [22]. To support our hypothesis
that ERK1/2 directly phosphorylate c-Jun in irradiated cells, we
looked for evidence of physical interaction between c-Jun and
ERK1/2. In GST pull-down assays, the bacterially expressed
6xHis tagged c-Jun was purified and individually incubated with
the beads containing GST-ERK1, GST-ERK2, and GST (as
a control). As shown in Figure 3A, both GST-ERK1 and GST-
ERK2 could specifically pull down His-tagged c-Jun protein, with
ERK2 showing a higher binding affinity than ERK1.
The JBD domain of c-Jun is required for interacting with JNKs
[17]. Although ERK1/2 and JNKs have been classified in the
ERK1/2 Mediated c-Jun Activation Post Irradiation
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36739Figure 2. ERK1 and ERK2 are indispensable for radiation-induced c-Jun phosphorylation in BV2 cells. (A) BV2 cells were transiently
cotransfected with ERK1 and ERK2 expression vectors in doses of 75, 150 and 300 ng for each plasmid. The total DNA amounts in transfection were
compensated with an empty vector. The transfected ERK1 and ERK2 led to a dose-dependent increase of phosphorylated ERK1/2 and c-Jun. (B) BV2
cells were treated with 10 mM ERK kinase inhibitor (Calbiochem Cat #328006) and DMSO as a control. Inhibitor-treated or untreated cells were
collected at 1 h after 10 Gy irradiation. Western blots showed that ERK kinase inhibitor abolished radiation-stimulated phosphorylation of ERK1/2 and
c-Jun. (C) To detect knockdown effects for ERK1 and ERK2 by lentiviral shRNA constructs in BV2 cells, two lentivirual shRNAs were prepared for each
ERK kinase, respectively, and used for infecting BV2 cells. The cells were collected 48 h after lentiviral infection and subjected for Western blot analysis
using the antibody against ERK1 (K32, sc-94), which also can recognize ERK2. Efficient depletion was found in the cell lysates infected with sh-ERK1-
974, sh-ERK2-321, and sh-ERK2-772, but not sh-ERK1-536. (D) BV2 cells were individually infected with scrambled control, ERK1, and ERK2 shRNA
lentiviruses, and subsequently irradiated with 10 Gy 48 h post infection and sampled at 1 h following radiation. There was no effect on radiation-
induced c-Jun phosphorylation by individual depletion of ERK kinases. (E) BV2 cells were infected with combined lentiviruses (sh-ERK1-974/sh-ERK2-
321 and sh-ERK1-974/sh-ERK2-772) and irradiated (10 Gy). Both shRNA combinations reduced radiation-stimulated phosphorylation of ERK1 and ERK2
to low levels, and decreased phosphorylated c-Jun after radiation. Bar graph depicts quantification (means 6 SD) of relative c-Jun phosphorylation
level, **p,0.01(#3 vs. #2; #4 vs. #2). (F) JNK levels in ERK1/2 knockdown BV2 cells.
doi:10.1371/journal.pone.0036739.g002
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36739Figure 3. ERK1 and ERK2 interact with c-Jun in vitro and in cells. (A) Direct protein interaction between c-Jun and ERK1/2. In GST pull-down
binding assays, purified 6xHis-c-Jun protein (1.0 mg) was individually incubated with GST-ERK1 and GST-ERK2 containing beads (3 mg each). After
extensive washing, an antibody (sc-45) against c-Jun was used to detect the 6xHis-c-Jun protein brought down from the glutathione agarose beads.
Lower panel: Ponceau S-stained membrane transferred with the GST fusion proteins. (B–D) In vitro protein binding studies to determine the binding
domains of ERK1/2 on c-Jun. (B). Schematic diagram of GST-fusion proteins created for wild-type c-Jun and truncated c-Jun including aa191-334 (DNA
binding domain), aa1-190 (JBD and transactivation domains), and aa1-62 (JBD domain). (C) and (D) Binding assays for GST-c-Jun mutants with 6xHis-
ERK1 and 6xHis-ERK2. (E) Interaction of endogenous c-Jun and phosphorylated ERK kinases in BV2 cells. BV2 cells were serum starved for 24 h and
then irradiated or sham-irradiated with a single dose of 10 Gy. Cell lysates were collected 1 h after irradiation. 0.75 mg cell lysates were used in co-
immunoprecipitation with the c-Jun antibody (sc-45). The phosphorylated and total ERK1/2 were detected with the antibody sc-81492 and sc-94,
respectively.
doi:10.1371/journal.pone.0036739.g003
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region on c-Jun protein. Thus, we created several constructs
expressing GST-fused truncation mutants that contain different c-
Jun domains (Figure 3B). In GST pull-down assays, purified
protein of 6xHis-ERK1 or 6xHis-ERK2 was incubated with GST
tagged wild-type c-Jun and its mutants (Figure 3C, 3D), re-
spectively. Both ERK1 and ERK2 showed a similar weak
interaction with the mutant (aa1-62) containing the JBD region;
however, they efficiently bound to either N- (aa1-190) or C-
(aa191-334) terminal c-Jun, revealing a binding pattern different
from that of JNKs. Results of protein binding assays suggest that
ERK1/2 may potentially mediate JNK-independent c-Jun acti-
vation.
We overexpressed Flag-c-Jun and HA-ERK1 or HA-ERK2 in
BV2 cells and observed that both HA-ERK1 and HA-ERK2 were
associated with Flag-c-Jun in a co-immunoprecipitation assay
(Figure S1). To further examine the association of endogenous c-
Jun and ERK1/2, we used a c-Jun specific antibody to
immunoprecipitate the BV2 cell lysate and then examined the
phosphorylated and total ERK1/2 in the precipitated proteins by
Western blots. As shown in Figure 3E, c-Jun antibody brought
down phosphorylated and total ERK proteins in both non-
irradiated and irradiated BV2 cells. The precipitated ERK1/2
were increased in irradiated BV2 cell lysates compared with
control samples, most likely due to the increased nuclear ERK1/2
(phosphorylated ERK1/2) stimulated by radiation. The higher
level of precipitated phorsphorylated ERK2 compared to ERK1 is
likely due to the different amounts of their phosphorylated forms
in BV2 cells as well as the relatively higher binding affinity of c-Jun
to ERK2 than ERK1.
MEK-ERK1/2 signaling pathway is responsible for
radiation-induced c-Jun phosphorylation
As the last downstream kinases in the Ras-Raf-MEK-ERK1/2
MAP kinase cascade, ERK1 and ERK2 are directly activated by
MEK [21]. To confirm that radiation-induced c-Jun phosphory-
lation is dependent on the activation of this MAP kinase signaling
pathway, we examined activation of MEK1 in irradiated BV2
cells. As shown in Figure 4A, radiation rapidly stimulated MEK1
phosphorylation. To validate the capability of MEK1 in modu-
lating c-Jun phosphorylation, HA-tagged wild type (WT) MEK1
and its kinase-dead mutant MEK1
K97M [24] were overexpressed
in BV2 cells by transient transfection. As shown in Figure 4B,
MEK1 (WT) dramatically induced phosphorylation of ERK1/2 as
well as c-Jun, while the vector or MEK1
K97M did not increase c-
Jun phosphorylation. We also treated the BV2 cells with U0126,
a MEK1 inhibitor, and observed markedly decreased phosphor-
ylation of ERK1/2 and c-Jun in the irradiated cells (Figure 4C,
and Figures S2A and S2B). To specifically disrupt MEK1
function, two lentiviral shRNAs constructs (sh-MEK1-212 and
sh-MEK1-495) with different target sequences on MEK1 were
generated. As illustrated in Figure 4D, and Figures S2C and S2D,
sh-MEK1-212 efficiently depleted MEK1 protein level in BV2
cells and concurrently reduced radiation-stimulated phosphoryla-
tion of both ERK1/2 and c-Jun. By contrast, the sh-MEK1-495
construct, which marginally decreased MEK1, did not block
radiation-increased phosphorylation of ERK1/2 and c-Jun.
Collectively, these results indicate that MEK1 is indispensable
for N-terminal c-Jun phosphorylation in response to radiation.
Our data also suggest that the canonical MEK1-ERK1/2
signaling pathway contributes to radiation-induced c-Jun activa-
tion.
JNK function on radiation-induced phosphorylation of c-
Jun
The members of JNK family are primary kinases responsible for
N-terminal phosphorylation of c-Jun under different physiological
conditions in multiple cell types [17,22]. A recent study showed
that the JNK inhibitor SP600125 could reduce c-Jun phosphor-
ylation in BV2 cells post-irradiation [25]. However, we did not
observe JNK activation in irradiated BV2 cells, suggesting that
JNKs may not be involved in modulation of c-Jun phosphorylation
following irradiation [25]. To reconcile these conflicting findings,
we treated BV2 cells with SP600125 and used the MEK inhibitor
U0126 as a control. We indeed detected the inhibitory effect of
SP600125 on c-Jun phosphorylation induced by radiation
(Figure 5A); however, the JNK inhibitor SP600125 also reduced
ERK1/2 phosphorylation (Figure 5A). We concluded that this
unexpected effect could contribute to the reduced c-Jun
phosphorylation reported previously [25]. Between these two
kinase inhibitors, U0126 exhibited much better inhibition on
ERK1/2 phosphorylation, but SP600125 showed a greater effect
in reducing c-Jun phosphorylation (Figure 5A). These results
suggest that JNKs, rather than ERK1/2, are key factors for basal
c-Jun phosphorylation. Due to its dual inhibitory roles in JNK and
ERK1/2, SP600125 would likely reduce both basal and radiation-
induced phosphorylation of c-Jun. Indeed, we found that
SP600125 was more potent than U0126 in reducing c-Jun
phosphorylation following irradiation (Figure 5A). Further studies
validated that JNK phosphorylation was decreased by SP600125,
but not U0126, in this inhibitor assay (Figure 5B). Overall, our
observations strongly suggested that radiation stimulates JNK-
independent c-Jun phosphorylation via an activated ERK1/2
pathway, while JNKs are critical for c-Jun phosphorylation in
other physiological conditions.
Radiation-induced c-Jun phosphorylation is mediated by
ROS
Cellular oxidative stress is one of primary consequences caused
by irradiation. We and others have observed increased generation
of reactive oxygen species (ROS) following radiation in various
cells, including microglia [25,26,27]. To test whether c-Jun
phosphorylation is dependent on increased generation of ROS
by irradiation, we treated BV2 cells with 100 mMH 2O2 and
observed that phosphorylated ERK1/2 and c-Jun were increased
in BV2 cells following H2O2 treatment (Figure 6A). Conversely,
we found that the treatment with 2.5 mM NAC, an antioxidant,
attenuated the c-Jun phosphorylation in a time-dependent manner
in irradiated BV2 cells (Figure 6B), revealing a delayed effect
associated with a gradual ROS decrease by this oxidant scavenger.
It is known that electron transport chain and NADPH oxidases are
generators of ROS following irradiation [2,26]. We therefore
tested several inhibitors to study the relationship between this type
of ROS generation and c-Jun activation. However we only found
that apocynin, an inhibitor of NADPH oxidases, could be used in
this study, because other tested inhibitors, such as TTFA,
rotenone, NaN3, and Dpi, could nonspecifically affect c-Jun
phosphorylation in non-irradiated BV2 cells (data not shown).
After preincubating BV2 cells with apocynin, we observed
a marked reduction of radiation-induced ROS in these cells
(Figure 6C). Importantly, apocynin treatment also decreased c-Jun
phosphorylation in response to irradiation (Figure 6D), suggesting
the importance of ROS on radiation-stimulated c-Jun function.
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its transcriptional activity
To validate the importance of c-Jun phosphorylation on Ser63
and Ser73 in BV2 cells, we conducted a Gal4/UAS Gaussia
luciferase assay [28,29] and found that both Ser63 and Ser73 were
critical for c-Jun transcriptional activity in this cell line (Figure S3).
c-Jun phosphorylation on Ser63/73 can stimulate its transcrip-
tional activity as well as DNA-binding ability [30,31]. To
determine whether the radiation-activated ERK1/2 signaling
pathway modulates c-Jun transcriptional function, c-Jun DNA
binding ability was examined using a EMSA assay. We in-
dividually incubated the nuclear extracts isolated from BV2 cells
with c-
32P labeled AP-1 probes. As shown in Figure 7A, radiation
caused a substantially high level of the retarded AP-1 probe,
suggesting enhanced DNA binding ability of c-Jun. Meanwhile,
the inhibitor U0126 markedly diminished radiation-mediated c-
Jun DNA binding ability (Figure 7A).
To further substantiate the role of ERK signaling pathway on c-
Jun transcriptional activity, we studied several well-characterized
c-Jun target genes, including four proinflammatory genes (COX-2,
Figure 4. MEK-ERK1/2 signaling pathway is required for radiation-induced c-Jun phosphorylation. (A) Cell lysates collected from 10 Gy-
irradiated BV2 cells were immunoblotted with anti-phosphorylated MEK1/2 (sc-7995R) antibody. (B) BV2 cells were transfected with HA-MEK1, HA-
MEK1
K97M (kinase-dead mutant), and vector control. Protein levels of p-c-Jun and p-ERK1/2 (upper and lower panels) are shown. (C) BV2 cells that
were treated or untreated with 10 mM U0126 were irradiated with 10 Gy. p-c-Jun and p-ERK1/2 levels were analyzed by Western blot. (D) Two shRNAs
(sh-MEK1-212 and sh-MEK1-495) were lentivirally delivered into BV2 cells to knockdown MEK1 protein. Knockdown efficiency and protein levels of p-
c-Jun and p-ERK1/2 were detected with the indicated antibodies. The quantification results for (C) and (D) are shown in Figure S2.
doi:10.1371/journal.pone.0036739.g004
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36739Figure 5. JNK function on c-Jun phosphorylation in BV2 cells. BV2 cells were individually treated with U0126 (10 mM) and the JNK inhibitor
SP600125 (5 mM). Cells were irradiated (10 Gy) or sham-irradiated. Cell lysates were collected 1 h post-irradiation. (A) Levels of p-c-Jun and p-ERK1/2
in the treated cells. (B) Levels of c-Jun, ERK, p-JNKs, and JNKs in the treated cells.
doi:10.1371/journal.pone.0036739.g005
Figure 6. ROS is associated with c-Jun phosphorylation. (A) 100 mM exogenous hydrogen peroxide was added into culture medium of BV2
cells. p-c-Jun and p-ERK1/2 were detected at the time points indicated. (B) c-Jun phosphorylation was detected for BV2 cell lysates treated or
untreated with 5 mM NAC at the indicated time points after radiation. (C) Inhibition of radiation-induced ROS in BV2 cells by 50 mM apocynin.
Intracellular ROS level was determined using the 29,7 9-Dichlorofluorescein diacetate (DCFA-DA) based method. Data represent mean 6 SD, *p,0.05.
(D) Apocynin was added into the BV2 cell culture medium and phosphorylation of c-Jun was analyzed in the apocynin-treated cell lysates.
doi:10.1371/journal.pone.0036739.g006
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36739Figure 7. Radiation-induced phosphorylation of c-Jun modulates its transcriptional activity. (A) Radiation-increased AP-1 DNA binding
ability was reduced by MEK kinase inhibitor U0126. To determine the effect of U0126 on c-Jun DNA binding ability, different nuclear extracts as
indicated were incubated with the c-
32p-labeled AP-1 consensus DNA probe. 5% acrylamide gel (0.56TBE) was used to resolve the products of the
binding reaction. Binding specificity is shown by the reaction only with BSA and competition with 50-fold excess non-radioactive consensus AP-1
oligonucleotide (cold AP-1 oligo). (B) BV2 cells were irradiated with 10 Gy dose with or without U0126. Cells were collected at the indicated time
points and subsequently used to detect the expression of c-Jun target genes. Protein levels of COX-2 and cyclin D1 were examined by Western blot
and transcription levels of TNFa, IL-1b, and IL-6 were examined by RT-PCR. (C) Real-time PCR was used to quantitatively analyze the expression of
TNFa, IL-1b, and IL-6. Data represent mean 6 SD, *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0036739.g007
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e36739TNFa, IL-1b, and IL-6) and cyclin D1[13,32,33,34,35] in
irradiated BV2 cells. We measured the expression of these
downstream genes by Western blots or RT-PCR. As shown in
Figure 7B, the expression of all these genes was induced by
irradiation. Additionally, inhibition of the ERK signaling pathway
led to decreased expression of these tested genes, consistent with
the observation in c-Jun DNA binding assay. In the quantitative
real-time PCR experiments, these proinflammatory genes were
significantly induced by irradiation and their induction was
significantly inhibited by blockade of the ERK signaling pathway
(Figure 7C).
In summary, we proposed a working model (Figure S4) based
on these findings. As depicted in this model, radiation-mediated
oxidative stress stimulates the MEK-ERK1/2 kinase cascade and
consequently activates c-Jun transcriptional function, leading to
the inflammatory response in microglial cells.
Discussion
Owing to its functional significance, c-Jun activation is subtly
regulated by various post-transcriptional modifications in cells,
such as phosphorylation, which have profound impacts on c-Jun
function. c-Jun is phosphorylated on multiple sites in different
cellular processes [36,37,38,39,40,41], mainly on its serine and
threonine residues. Phosphorylation can occur on the Ser63,
Ser73, Thr91, and Thr93 sites within the transactivation domain
located on the c-Jun N-terminus. In addition, residues located
proximal to the C-terminal DNA-binding domain, such as
Thr231, Thr239, Ser243, and Ser249, are also targeted by
different kinases, respectively [19]. N-terminal phosphorylation
determines whether c-Jun is transcriptionally active [17,23]; by
contrast, phosphorylation on other regions of c-Jun may impair its
DNA-binding ability, leading to a compromised transcriptional
activity [17,42]. The N-terminal residues Ser63 and Ser73 on c-
Jun protein are more functionally important and better charac-
terized than other phosphorylation sites. The phosphorylation of
these two serines significantly activates c-Jun transcriptional
activity [17] and can be induced by various stimuli, such as
lipopolysaccharide (LPS), TNFa, phorbol ester (TPA), EGF, and
ultraviolet light, which are related to multiple biological processes
[19,43]. In this study, we reported that c-Jun was rapidly activated
through Ser63/Ser73 phosphorylation in irradiated microglial
cells. Our study implicates that radiation-stimulated c-Jun
activation correlates with increased expression of proinflammatory
factors and may potentially lead to microglial activation in brain.
In the mammalian kinome, MAPKs are predominantly re-
sponsible for c-Jun phosphorylation on Ser63 and Ser73. JNKs
were initially identified and are generally recognized as the
preferential enzymes for c-Jun N-terminal phosphorylation,
especially on Ser63 and Ser73. JNK kinases bind to a small
portion of the c-Jun N-terminus and consequently exert their
kinase function on c-Jun [17]. In addition to JNKs, other MAPKs
were also found to regulate c-Jun phosphorylation in different
cellular processes. The requirement of different subtypes of
MAPKs may depend on cell type and/or cellular context. In T-
lymphocytes, P38 mediates a specific function for c-Jun phos-
phorylation in a JNK-independent manner [39]. In mouse
fibroblasts isolated from JNK-deficient mice, the ERK1/ERK2
pathway substituted for JNKs to mediate TPA- and EGF-induced
phosphorylation of c-Jun on Ser63 and Ser73 [19]. Moreover,
ERK1 and ERK2 directly phosphorylated c-Jun on Ser63 and
Ser73 in vitro [19,44]. Despite these findings, the physiological
roles of ERK1/2 on c-Jun phosphorylation have rarely been
addressed.
Our study indicated that the ERK1/2, but not the JNKs, were
rapidly phosphorylated in microglial cells after irradiation. We
provided multiple lines of evidence using overexpression, phar-
macological inhibitor, and gene knockdown approaches to prove
that both ERK1 and ERK2 are indispensable for radiation-
induced c-Jun phosphorylation on Ser63 and Ser73. In accor-
dance with this novel discovery, ERK1 and ERK2 directly interact
with c-Jun in vitro, and their phosphorylated forms are
endogenously associated with c-Jun in cells. Interestingly, ERK2
was more efficient than ERK1 in binding to c-Jun in vitro,
although they are highly homologous to each other. Meanwhile,
the phosphorylated form of ERK2 is more abundant than that of
ERK1 in BV2 cells, as indicated by Western blots. However, it
seems that these differences do not make ERK2 more important in
mediating c-Jun phosphorylation, since individual knockdown of
these two kinases was insufficient in blocking radiation-induced c-
Jun phosphorylation in our study, suggesting that ERK1 and
ERK2 are functionally compensating each other in regulating c-
Jun. Despite functional resemblance between ERK1/2 and JNKs,
discrepancies exist between these two subtypes of MAPKs in their
binding pattern with c-Jun. The N-terminal c-Jun contains the
JBD region that is indispensable for JNK-mediated c-Jun
phosphorylation. However, the c-Jun mutant (aa1-62) containing
JBD region showed a weaker binding ability to ERK1 and ERK2,
compared to other c-Jun truncation mutants. Our mapping study
could not further define a specific ERK-binding domain on c-Jun,
since it appears that multiple regions of c-Jun are likely involved in
its interaction with ERKs.
ERK 1 and ERK2 are autophosphorylable on both threonine
and tyrosine residues and the autophosphorylation correlates with
their activation [45]. However, our results suggest that the
autophosphorylation may not play an important role in their
radiation-stimulated activation, due to the dependence of MEK1
function. Our data demonstrated that MEK1 can be activated in
response to irradiation. More importantly, MEK1 knockdown led
to the expected consequences, such as reduced phosphorylation of
both ERKs and c-Jun in irradiated BV2 cells. Therefore,
radiation-induced c-Jun phosphorylation depends on the canon-
ical MEK-ERK signaling pathway. Further definition of function
for other components in this signaling pathway will depict a more
complete picture of radiation-induced c-Jun activation.
ROS generation is one of the earliest cellular responses after
ionizing radiation [46]. Radiation-caused ROS can be generated
through oxidation of cellular water, leakage of the mitochondrial
electron chain, or elevated activation of NADPH oxidases [2,26].
The increased radicals and ROS, including superoxides, hydrogen
peroxide, and hydroxyl radicals, can attack neighbor cells and
alter gene transcription, consequently leading to cellular lesions
and other responses such as DNA damage and inflammation.
Therefore, ROS production has been thought to be a critical
factor associated with radiation-caused acute and chronic brain
injury [2]. However, the exact molecular mechanisms by which
radiation-induced oxidative stress mediates brain injury are so far
insufficiently understood. In this regard, our study provided new
insights into radiation-induced microglial activation. Our exper-
imental data suggest that elevated ROS level following irradiation
likely triggers the activation of ERK signaling in microglial cells,
which can eventually control inflammatory gene expression
through the modulation of c-Jun transcriptional activity.
We found that radiation did not increase expression and
activation of RelA/p65, an important component of NF-kB
signaling pathway, in the irradiated BV2 cells, and the MEK
inhibitor had no effect on RelA/p65 (Figure S5). However, we
demonstrated that the activated ERK/c-Jun signaling pathway is
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flammatory genes in microglial cells. Many studies have shown
that the MAPK pathway and c-Jun phosphorylation of Ser63 and
Ser73 can be stimulated by LPS and other proinflammatory
factors, such as TNFa and interleukins [19,47,48,49]. We
speculate that the accumulation of these proinflammatory factors
may modulate radiation-induced c-Jun phosphorylation to further
enhance c-Jun activation. Combined with previous studies, our
findings suggest that c-Jun acts as a signaling amplifier through
a positive feedback mechanism to augment inflammatory gene
expression and consequently promotes radiation-caused neuroin-
flammation. Taken together, our study demonstrated the in-
volvement of the MEK/ERK/c-Jun signaling pathway in
radiation-induced microglial inflammation responses and sug-
gested that clinical interventions using this information may help
minimize side effects caused by brain radiation therapy.
Materials and Methods
Reagents and antibodies
ERK inhibitor [3-(2-Aminoethyl)-5-(4-ethoxyphenyl) methy-
lene)-2,4-thiazolidinedione, HCl, Calbiochem Cat #328006],
U0126 and SP600125 were purchased from Calbiochem (EMD
Biosciences, La Jolla, CA). The antioxidant N-acetyl-L-cysteine
(NAC) was purchased from Sigma-Aldrich Corporation (St. Louis,
MO). The antibodies for JNK (#9258), phosphorylated JNK
(Thr/183/Thr185, #9255), cyclin D1 (#2926) and phosphory-
lated c-Jun (Ser63, #2361) were purchased from Cell Signaling
Technology (Beverly, MA). Antibodies for c-Jun (sc-45), phos-
phorylated c-Jun (Ser73, sc-7981), ERK1 (sc-94), phosphorylated
ERK1/2 (Thr202/Thr204, sc-81492), phosphorylated MEK (sc-
7995R), COX-2 (sc-1745) and HA (sc-7392) were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). MEK antibody (RB-
1662) was purchased from Thermo Scientific (Waltham, MA).
Cell cultures, transfection and treatments
Murine microglial BV2 cells [50] were cultured in high glucose
DMEM medium supplemented with 5% fetal bovine serum (FBS)
at 37uC with 10% CO2. Cells were transiently transfected with
varied amounts of plasmids using Fugene HD (Roche Applied
Science) according to the manufacturer’s instruction. Forty-eight
hours post transfection, the cells were subjected to further analysis.
BV2 cells were used under passage 30. In the kinase inhibitor
assay, the inhibitors were supplemented to culture medium 1 h
before exposure to irradiation. For radiation treatment, cells were
starved with serum-free DMEM medium for 24 h prior to
irradiation. Cells were irradiated with a
137Cs irradiator (J.L.
Shepherd and Associates, San Fernando, CA) at a dose rate of
3.7 Gy/min. All irradiations were performed at room tempera-
ture; control cells were received sham irradiation. After irradia-
tion, the culture dishes were returned to the incubator.
DNA constructs
In this study, murine cDNAs of c-Jun, ERK1, ERK2, and
MEK1 were cloned into appropriate expression vectors, and the
shRNA constructs were designed to target murine mRNA
sequences. The expression plasmids pCMV-SPORTS6/ERK1
and pCMV-SPORTS6/ERK2 were obtained from Open Biosys-
tems (Thermo Scientific, Waltham, MA). The coding regions of c-
Jun and MEK1 were amplified with RT-PCR using cDNA from
BV2 cells and subcloned into different vectors. The kinase-dead
MEK1 (MEK1
K97M) [24] was created by PCR-based site-directed
mutagenesis. pSL2/HA vector [28] was used to overexpress HA-
tagged wild-type and the mutant MEK1 in mammalian cells. To
bacterially express ERK1, ERK2 and c-Jun mutants, the
corresponding coding fragments were inserted into vectors to
form glutathione S-transferase (GST)-tagged or 6xHis-tagged
fusion proteins. The c-Jun truncation mutants, including aa1-62,
aa1-190, and aa191-334, were generated by PCR methods. To
achieve efficient gene knockdown, lentivirus-based shRNAs were
delivered into BV2 cells by infection. shRNA expression vectors
were constructed on the lentiviral vector pLu containing mouse
U6 promoter as detailed previously [28]. The target sequences
used for shRNA construction are sh-ERK1-536 (gcgaccttaa-
gatctgtgatt), sh-ERK1-974 (gcgcatcacagtagaggaagc), sh-ERK2-
321 (gacggacctttacaagctctt), sh-ERK2-772 (gctagaaactatttgctttctc),
sh-MEK1-212 (ggatgatgactttgagaagat), and sh-MEK1-495 (ggaa-
gaattcctgagcaaatt). The scrambled control was described elsewhere
[51]. The shRNA plasmids were constructed using a methodology
described previously [52]. The primer sequences are detailed in
the Table S1.
GST pull-down assay and co-immunoprecipitation
GST pull-down assays were performed as described previously
[51]. Co-immunoprecipitation was carried out to detect the
endogenous interaction between phosphorylated ERK1/2 and c-
Jun. 750 mg of BV2 cell lysates were incubated with c-Jun
polyclonal antibody (sc-45; Santa Cruz) for 2 h at 4uC in a binding
buffer [0.05 M Tris-HCl (pH 7.5), 0.15 M NaCl, 5 mM EDTA,
0.1% NP-40] containing PSFM and 1x protease inhibitor cocktail
(Roche Applied Science), followed by incubation with protein G-
agarose (Invitrogen, Carlsbad, CA) for 2 h. After extensive
washing with the binding buffer, the samples were analyzed by
Western blot using the p-ERK1/2 antibody (sc-81492) and ERK1
antibody (sc-94), respectively.
Lentiviral infection
shRNA lentiviral production was performed by co-transfecting
293FT cells with lentiviral shRNA vectors together with the
packaging plasmids: pVSV-G, pRSV-REV, and pMDLg/pRRE.
The medium was filtrated with a 0.45 m filter 48 h post-
transfection and then ultracentrifuged (25,000 rpm for 1.5 h) to
concentrate viral particles. To infect BV2 cells, the medium was
added with concentrated lentivirus and polybrene (8 mg/ml) and
incubated for 6 h before replacing with normal medium.
Real-time PCR
The primers used for real-time PCR were: mTNFa (F:
CACCACCATCAAGGACTC/R: AGGTCTGAAGGTAG-
GAAGG), mIL-1b (F: ATCCGTGTCTTCCTAAAGTATG/R:
CCTGAGCGACCTGTCTTG), mCOX-2 (F:
TGTCTTCCAGCCCATTGAAC/R: CAGCGTTTCTCG-
TAGTAAAGTG), mIL-6 (F: GCTGGAGTCACAGAAGGAG/
R: GAGAACAACATAAGTCAGATACC), and GAPDH (F:
GCCTTCCGTGTTCCTACC/R: CTTCACCACCTTCTT-
GATGTC). Total RNA was prepared by Trizol (Invitrogen,
Carlsbad, CA) method, and further purified with the RNeasy Mini
kit (Qiagen, Santa Clarita, CA) after DNase I treatment. Reverse
transcription was performed with MMLV (Invitrogen, Carlsbad,
CA) following the manufacturer’s instructions. Real-time PCR was
performed at ABI7000 using FastStart universal SYBR green
master mix (Rox) (Roche Applied Science, Mannheim, Germany).
The samples were analyzed in quadruplicate and repeated in three
independent experiments. The comparative Ct method was used to
calculate relative levels of gene expression based on normalization
to GAPDH.
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Nuclear protein was extracted from treated and untreated BV2
cells following a procedure described previously [53]. Protein
concentrations were determined by a BCA kit (Pierce, Rockford,
IL). The AP-1 probe consisted of annealed oligonucleotides of the
consensus AP-1-binding sequence (59-CGCTTGATGAGT-
CAGCCGGAA-39 and 39-GCGAACTACTCAGTCGGCCTT-
59), which was labeled with c-
32P-ATP (Perkin Elmer Life and
Analytical Sciences, Waltham, MA) using T4 polynucleotide
kinase (Promega, Madison, WI). The labeled probe was cleaned
with a Sephadex G-25 column (GE Healthcare) to remove the free
c-
32P-ATP and radioactivity was quantified using the LS6500
liquid scintillation counter (Beckman Coulter, Fullerton, CA). The
EMSA procedure was performed by using the Gel-Shift Core
Assay Kit (Promega, Madison, WI) with slight modifications.
Briefly, 10 mg of nuclear protein was incubated with labeled AP-1
probe (,150 cpm/reaction) at 37uC for 1 h. The binding
products were then resolved on a 5% native polyacrylamide gel
(0.56 TBE). The gel was subsequently vacuum-dried (Thermo
Scientific, Waltham, MA) for 2 h at 85uC before autoradiography.
Statistical analysis
All experimental data were collected, unless otherwise indicated,
from 3 independent experiments, and presented as mean 6 SD.
Statistical analysis was performed with SigmaPlot 10.0 (Systat
Software, San Jose, CA) and Student’s t test was used to evaluate
significance of differences between two groups. A P value of ,0.05
was considered statistically significant.
Supporting Information
Figure S1 Protein interaction between c-Jun and ERK1/
2 in cells. A lentivirual vector pSL2 was used to construct
overexpression vectors for HA-ERK1, HA-ERK2, and Flag-c-Jun.
BV2 cells were infected with the lentiviruses to express the
indicated proteins. Forty-eight hours after infection, cell lysates
were subjected to immunoprecipitation assay with the anti-Flag
antibody (sc-807, Santa Cruz Biotech) and control antibody, and
then the HA monoclonal antibody (sc-7392, Santa Cruz Biotech)
was used to detect the precipitated HA-ERK1 or HA-ERK2 in
a Western blot assay. To show binding specificity, the cell lysates
expressing HA-ERK1 or HA-ERK2 alone were included in the
co-immunoprecipitation assay. The expression of Flag-c-Jun, HA-
ERK1, HA-ERK2, and GAPDH (loading control) in the co-
immunoprecipitation lysates is shown in the lower panel, re-
spectively.
(PDF)
Figure S2 The relative levels of p-c-Jun and p-ERK1/2
in Western blots normalized against the levels of their
total proteins. Quantification was performed with the Quantity
One 1-D Analysis software (Bio-Rad, Richmond, CA). (A) and (B)
Quantification results of p-c-Jun and p-ERK1/2 in U0126
inhibitor assay shown in Figure 4C. (C) and (D) Quantification
results of p-c-Jun and p-ERK1/2 in MEK knockdown experiment
shown in Figure 4D. Data represent mean 6 SD, *p,0.05;
**p,0.01.
(PDF)
Figure S3 Ser63 and 73 are critical for c-Jun activity in
BV2 cells. (A) Schematic diagram for 4XUAS reporter and Gal4-
c-Jun fusion constructs. 4XUAS was amplified from 4XUAS-TK-
Luc [29] and inserted into the pGLuc-Basic vector (New England
Biolabs) containing the Gaussia luciferase reporter gene. The
indicated partial c-Jun containing transcription activation (TA)
domain was used to detect c-Jun transcriptional activity. Three
mutants were created for c-Jun (TA), in which Ser63 and Ser73
were replaced with alanine separately or together. The resulting c-
Jun variants were in frame fused with the Gal4 DNA binding
domain (DBD) in the pcDNA3 vector. (B) BV2 cells were
cotransfected with 75 ng Gal4-c-Jun (TA) and its mutants,
together with 300 ng 4xUAS-Gluc reporter and 100 ng SEAP
expression vector as an internal control. Cells were irradiated with
10 Gy 30 h after transfection and medium were collected 4 h after
radiation treatment for measuring luciferase activity. The
measurement method was detailed previously [28]. The relative
reporter activities were normalized against SEAP activity.
Experiments were performed twice in triplicate. Data represent
mean 6 SD, and differences were evaluated between the effects of
wild-type and mutant c-Jun, *p,0.05.
(PDF)
Figure S4 Model for radiation-induced c-Jun phosphor-
ylation and its role in neuroinflammation.
(PDF)
Figure S5 Radiation does not induce NFkB activation in
BV2 cells. (A) RelA/p65 level in the irradiated BV2 cells. (B)
Levels of nuclear form of RelA/p65 in irradiated BV2 cells with or
without MEK inhibitor U0126 treatment. Histone H3 and
Ponceau S staining represent loading controls for the nuclear
extracts.
(PDF)
Table S1 Primers for cloning.
(DOC)
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